Current treatment options and drug delivery systems as potential therapeutic agents for ovarian cancer: A review-Reference-Cited by-同舟云学术

Current treatment options and drug delivery systems as potential therapeutic agents for ovarian cancer: A review

Published:2014-12 Issue: Volume:45 Page:609-619
ISSN:0928-4931
Container-title:Materials Science and Engineering: C
language:en
Short-container-title:Materials Science and Engineering: C

Author:

Ye Hongye,Karim Anis Abdul,Loh Xian Jun

Publisher

Elsevier BV

Subject

Biomaterials,Bioengineering,Mechanics of Materials

Reference84 articles.

1. American Cancer Society, 2013. [http://www.cancer.org/cancer/ovariancancer/detailedguide/ovarian-cancer-key-statistics, Last Medical Review: 03/21/2013 Last Revised: 02/06/2014]

2. Surveillance, Epidemiology and End Results (SEER) Program of the National Cancer Institute,2008

3. Cancer of the Ovary

4. Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: Experimental study in a murine model of ovarian cancer

5. Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implantable CAR T cell factories enhance solid tumor treatment;Biomaterials;2024-07

2. A Comprehensive Review on Current Treatments and Challenges Involved in the Treatment of Ovarian Cancer;Current Cancer Drug Targets;2024-02

3. Delivery of gefitinib loaded nanoparticles for effectively inhibiting prostate cancer progression;Biomaterials Science;2024

4. Anti-cancer effect of fenbendazole-incorporated PLGA nanoparticles in ovarian cancer;Journal of Gynecologic Oncology;2023

5. Implantable Car T Cell Factories Enhance Solid Tumor Treatment;2023